Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations

Gynecologic Oncology
James R ConnerColleen Feltmate

Abstract

This study computed the risk of clinically silent adnexal neoplasia in women with germ-line BRCA1 or BRCA2 mutations (BRCA(m+)) and determined recurrence risk. We analyzed risk reduction salpingo-oophorectomies (RRSOs) from 349 BRCA(m+) women processed by the SEE-FIM protocol and addressed recurrence rates for 29 neoplasms from three institutions. Nineteen neoplasms (5.4%) were identified at one institution, 9.2% of BRCA1 and 3.4% of BRCA2 mutation-positive women. Fourteen had a high-grade tubal intraepithelial neoplasm (HGTIN, 74%). Mean age (54.4) was higher than the BRCA(m+) cohort without neoplasia (47.8) and frequency increased with age (p < 0.001). Twenty-nine BRCA(m+) patients with neoplasia from three institutions were followed for a median of 5 years (1-8 years.). One of 11 with HGTIN alone (9%) recurred at 4 years, in contrast to 3 of 18 with invasion or involvement of other sites (16.7%). All but two are currently alive. Among the 29 patients in the three institution cohort, mean ages for HGTIN and advanced disease were 49.2 and 57.7 (p = 0.027). Adnexal neoplasia is present in 5-6% of RRSOs, is more common in women with BRCA1 mutations, and recurs in 9% of women with HGTIN alone. The lag in time from diagnosis of th...Continue Reading

References

Apr 29, 2000·Gynecologic Oncology·P G RoseG L Wiesner
Dec 12, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Bruce A WernessM Steven Piver
Jan 26, 2006·The American Journal of Surgical Pathology·Fabiola MedeirosChristopher P Crum
Jul 13, 2006·JAMA : the Journal of the American Medical Association·Amy FinchUNKNOWN Hereditary Ovarian Cancer Clinical Study Group
Jan 27, 2007·The American Journal of Surgical Pathology·David W KindelbergerChristopher P Crum
Sep 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J CallahanMichael G Muto
Mar 12, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·R ManchandaU Menon
Jun 20, 2012·Gynecologic Oncology·Marjanka J J M MingelsMijke Bol
Aug 28, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Welmoed ReitsmaMarian J E Mourits
Nov 1, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Stephanie L WethingtonGinger J Gardner

❮ Previous
Next ❯

Citations

Oct 22, 2014·The Journal of Obstetrics and Gynaecology Research·Felix ZeppernickIe-Ming Shih
Mar 26, 2016·The American Journal of Pathology·Robert J Kurman, Ie-Ming Shih
May 21, 2016·Frontiers in Oncology·Sophia H L GeorgeBrian M Slomovitz
Jun 9, 2016·CA: a Cancer Journal for Clinicians·Lysandra VoltaggioElizabeth A Montgomery
Oct 13, 2016·Expert Review of Anticancer Therapy·Vit WeinbergerMichal Zikan
Jan 21, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Emily E K MeserveChristopher P Crum
Dec 10, 2014·Current Opinion in Obstetrics & Gynecology·C Bethan Powell
Nov 30, 2016·Current Opinion in Obstetrics & Gynecology·Paul T Kroeger, Ronny Drapkin
Feb 12, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Stephanie SchneiderAndreas du Bois
Aug 5, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Carolin PoonKerryn Ireland Jenkin
Jan 26, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jaime Prat, Robert H Young
Sep 16, 2017·Advances in Anatomic Pathology·Lien N Hoang, Blake C Gilks
Oct 29, 2019·Cancer Biomarkers : Section a of Disease Markers·Dmitriy W GutkinAnna Lokshin
Sep 29, 2017·Clinical Obstetrics and Gynecology·Maria G PatronoPedro T Ramirez
Mar 16, 2016·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Naveena SinghW Glenn McCluggage
Oct 25, 2017·Nature Communications·S Intidhar Labidi-GalyVictor E Velculescu
Apr 30, 2019·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Marie E PerroneMark R Kilgore
Jan 13, 2015·The American Journal of Surgical Pathology·Brooke E HowittEmily E Meserve
Dec 17, 2014·Current Opinion in Obstetrics & Gynecology·Jocelyn S ChapmanLee-May Chen
Dec 7, 2018·The Journal of Obstetrics and Gynaecology Research·Natthawadee LaokulrathSuchanan Hanamornroongruang
Jul 19, 2017·Clinical Obstetrics and Gynecology·Anthony N Karnezis, Kathleen R Cho
May 2, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Joanne KotsopoulosSteven A Narod
Mar 25, 2015·Cancer Prevention Research·Mark H Greene, Phuong L Mai
Dec 17, 2015·Cancer Research·Ruth Perets, Ronny Drapkin
Oct 9, 2019·Psychosomatic Medicine·Claudia Trudel-FitzgeraldShelley S Tworoger
Sep 8, 2021·Nature Reviews. Cancer·Gabriel A KwongSangeeta N Bhatia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.